F2-Isoprostane / Creatinine (Urine)

What F2-Isoprostane / Creatinine (Urine) actually measures — the analyte, and the assay

An isoprostane is damage, not a signal. F2-isoprostanes are made when a free radical attacks arachidonic acid while it is still esterified in a membrane phospholipid. No enzyme directs it. The product is a prostaglandin-F2-like ring compound that a phospholipase then releases into circulation, and 8-iso-PGF2α — also written 15-F_2t-isoprostane — is one member of a family of 64 possible stereoisomers across four regioisomeric classes.

Which of those 64 an antibody binds is the whole problem. The reference method is mass spectrometry with a stable-isotope internal standard, which separates the target isomer chromatographically before measuring it. An enzyme immunoassay does not separate anything; it presents an antibody to a mixture and reports what sticks.

The size of the resulting disagreement is not subtle. Across 25 paired human plasma and urine samples, three commercial ELISAs reported concentrations 2.1 to 182.2 times higher in plasma and 0.4 to 61.9 times higher in urine than liquid chromatography-tandem mass spectrometry on the same specimens. The paper's title is its conclusion: the two kinds of result cannot be compared Klawitter 2011. The same verdict has been set out for urinary F2-isoprostanes specifically Tsikas 2012.

And the result you are given is a ratio, not a concentration. Urinary isoprostane is reported per milligram of creatinine, so half of your number is a measurement of something else entirely.

F2-Isoprostane / Creatinine (Urine): what changes the blood, and what only changes the reading

What changes the isoprostane load in your body:

1. Radical flux against membrane arachidonic acid. The rate of the reaction depends on how much oxidant pressure meets how much polyunsaturated substrate, which is why smoking raises it, why hyperglycemia raises it, and why adiposity raises it.
2. How much arachidonic acid is in the membrane in the first place, which diet and the omega-6 to omega-3 balance influence. More substrate means more product at the same oxidant pressure.
3. Acute strenuous exercise, which transiently increases oxidant production — so a sample collected the morning after a hard session is measuring the session.
4. Phospholipase activity, which governs release of the formed isoprostane from the membrane into a fluid where it can be measured.

What changes only the reading — and on this marker the measurement effects are larger than anything on the list above:

1. ELISA or mass spectrometry. Up to a 182-fold difference on the same sample Klawitter 2011. There is no correction factor and no way to interpret one against the other Tsikas 2012.
2. The creatinine denominator, which can invent a difference that is not there. In a study of 36 vegans and 36 omnivores, absolute 24-hour excretion of a marker compound was not different between the groups — yet after creatinine adjustment the omnivores looked 26% lower (median 285 against 383 µg/g creatinine, P = 0.003), purely because they excreted more creatinine (1.51 against 1.21 g/24 h, P = 0.009). Adjusting instead for specific gravity shrank the apparent gap to 13% and it stopped being statistically significant Abraham 2023.
3. Anything that moves creatinine excretion: muscle mass, a creatine supplement, a meat-heavy day, and above all a change in filtration rate, which invalidates creatinine normalization while the rate is changing Waikar 2010.
4. Spot urine or timed collection. A first-morning void, a random afternoon sample and a 24-hour collection are three different measurements of one person.
5. Ex vivo autoxidation. Arachidonic acid in a stored sample keeps oxidizing. Without an added antioxidant and prompt freezing, storage manufactures the analyte the assay is looking for.

Reference interval or decision threshold — which kind of number F2-Isoprostane / Creatinine (Urine) is

Neither — and that is the accurate answer. There is no reference interval for urinary F2-isoprostane that transfers between laboratories, because the two dominant methods do not measure the same thing Klawitter 2011, and there is no decision threshold because no value has been tied to an action.

What a laboratory prints is its own method's distribution. That is a legitimate thing to print and an illegitimate thing to compare against a number from anywhere else.

Lower is a defensible direction rather than a target. The site's own optimal line for this marker says so, and the reason is structural: a value has meaning only against a previous value from the same method, the same matrix and the same normalization.

Plasma and urinary measurements are not two views of one number. They diverged in opposite directions in the same comparison study — ELISA overshot mass spectrometry by up to 182-fold in plasma and by up to 62-fold in urine, with one assay reading below mass spectrometry in urine at 0.4-fold Klawitter 2011.

How you would know your F2-Isoprostane / Creatinine (Urine) was wrong — and when to redraw

Isoprostane formation is continuous, so the clock is the collection's, not the molecule's. Urine integrates production over the hours it accumulated, which is why a timed collection is steadier than a spot sample and why 3 to 6 months is the sensible spacing after an intervention — long enough for a real change in oxidant pressure, short enough that the assay has not been reconfigured.

Conditions that must match: the same laboratory and the same method class, the same collection type and time of day, at least 48 hours clear of hard training, and a stable filtration rate Waikar 2010.

How you would know the change was in the denominator:

• Ask for the unadjusted concentration and the urine creatinine alongside the ratio. If the raw isoprostane held steady and the ratio moved, your creatinine moved — and creatinine is muscle and diet Abraham 2023.
• Check whether anything changed that alters creatinine output: a new training block, a creatine supplement, a shift in protein intake, weight change.
• Put an hs-CRP and an HbA1c beside it. If oxidant pressure genuinely fell, the markers that share its drivers should be moving in the same direction; if they are flat, the isoprostane change is probably analytical.
• Never compare a mass-spectrometry result with an ELISA result. A fall from one to the other is a change of laboratory Klawitter 2011.

What F2-Isoprostane / Creatinine (Urine) cannot tell you

It cannot tell you where the oxidation happened. A urinary isoprostane is a whole-body integral. Brain, vessel wall, liver and skeletal muscle all drain into the same number, and none of them is identifiable in it.

It cannot tell you that lowering it helps. No intervention has been shown to reduce a clinical outcome by way of lowering this measurement, which places it in the same category as the Lp-PLA2 Activity page's central caution.

It cannot be interpreted without its denominator. A ratio with a moving bottom is two measurements pretending to be one, and the 26% artifact demonstrated between diet groups is the clean proof Abraham 2023.

It cannot be compared with a published figure, because the published figure was produced by one of two methods that disagree by up to two orders of magnitude Klawitter 2011 Tsikas 2012.

The wrong inference readers actually draw is that a falling F2-isoprostane after starting an antioxidant proves the antioxidant worked. Before that conclusion survives, the raw concentration, the creatinine, the collection type and the assay all have to have stayed still — and in most real retests at least one of them did not.

Sources read for these sections

• Klawitter J, et al. Quantification of 15-F2t-isoprostane in human plasma and urine: results from enzyme-linked immunoassay and liquid chromatography/tandem mass spectrometry cannot be compared. Rapid Communications in Mass Spectrometry 2011 · PMID 21259353
• Tsikas D. Assessment of urinary F(2)-isoprostanes in experimental and clinical studies: mass spectrometry versus ELISA. Hypertension 2012 · PMID 22753209
• Abraham K, et al. Risks of misinterpretation of biomarker measurements in spot urine adjusted for creatinine - A problem especially for studies comparing plant based with omnivorous diets. International Journal of Hygiene and Environmental Health 2023 · PMID 36842230
• Waikar SS, et al. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney International 2010 · PMID 20555318